Your browser doesn't support javascript.
loading
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.
Dutzmann, Jochen; Musmann, Robert-Jonathan; Haertlé, Marco; Daniel, Jan-Marcus; Sonnenschein, Kristina; Schäfer, Andreas; Kolkhof, Peter; Bauersachs, Johann; Sedding, Daniel G.
Afiliación
  • Dutzmann J; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Musmann RJ; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Haertlé M; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Daniel JM; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Sonnenschein K; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Schäfer A; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Kolkhof P; Global Drug Discovery, Cardiology Research, Bayer AG, Wuppertal, Germany.
  • Bauersachs J; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Sedding DG; Dept. of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
PLoS One ; 12(9): e0184888, 2017.
Article en En | MEDLINE | ID: mdl-28926607

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Traumatismos de las Arterias Carótidas / Antagonistas de Receptores de Mineralocorticoides / Naftiridinas Tipo de estudio: Etiology_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Traumatismos de las Arterias Carótidas / Antagonistas de Receptores de Mineralocorticoides / Naftiridinas Tipo de estudio: Etiology_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article